Navigation Links
Protein protects lung cancer cells from efforts to fix or kill them
Date:2/28/2008

GAINESVILLE, Fla. --- A protein that helps lung cancer cells thrive appears to do so by blocking healthy cells ability to fix themselves when radiation or chemicals such as nicotine damage their DNA, according to a University of Florida study to be published Friday (Feb. 29) in the journal Molecular Cell.

High levels of the protein, known as Bc12, are found in the cells of lung cancer patients who smoke.

Previous UF research has shown that nicotine activates the protein, which helps tumor cells live long past their natural lifespan and resist chemotherapy. The new findings explain how the protein enables cancer cells to circumvent the bodys own efforts to change them back into healthy cells -- or evade treatments designed to kill them.

Cancer is frequently associated with the accumulation of genetic aberrations in cells chromosomes. If these damaged cells cant access their built-in repair system and subsequently survive long enough to divide and multiply, they pass along their mutations.

If a cell experiences DNA damage, often that DNA can be repaired. But we found that Bc12 can block the DNA repair mechanism, which promotes tumor formation and genetic instability, said Dr. Xingming Deng, an assistant professor in UFs College of Medicine who is affiliated with the UF Shands Cancer Center. This is a very important fundamental mechanism that explains why this protein has (a cancer-forming) function.

Researchers say just one cell that develops a genetic mutation and is unable to repair itself could be enough for a full-blown tumor to develop.

Lung cancer is the No. 1 killer of all cancer types; it is the most dangerous, Deng said. We wanted to find a way to treat lung cancer, how to prevent lung cancer, because lung cancer prognosis is very poor.

Nearly 162,000 people will die from lung cancer in 2008, accounting for about 29 percent of all cancer deaths, according to the American Cancer Society. More people die of lung cancer than of colon, breast and prostate cancers combined.

In the study, UF scientists performed a series of laboratory experiments on lung cancer cells in culture that illuminated the molecular chain of events that allows Bc12 to disrupt DNA repair.

Deng also plans to explore the possibility that nicotine-induced activation of Bc12 can be blocked to increase chemotherapys effectiveness.

This will probably help us in the future find ways to prevent tumors, said Deng, adding that the protein could be a target for drug development. We can target this mechanism and somehow find a way to prevent tumor formation.


'/>"/>

Contact: Melanie Fridl Ross
ufcardiac@aol.com
352-690-7051
University of Florida
Source:Eurekalert

Related biology news :

1. Proteins strength lies in h-bond cooperation
2. Moss protein plays role in Alzheimers disease
3. Scientists rebuild ancient proteins to reveal primordial Earths temperature
4. Carnegie Mellon scientists develop fluorescent proteins for live cell imaging, biosensor design
5. Unique whey protein is promising supplement for strict PKU diet
6. Its all about geometry: Protein contact surfaces hold key to cures
7. Stowers Proteomics Center devises method for assigning probabilities to human protein interactions
8. New Argonne study may shed light on protein-drug interactions
9. Proteins new role discovered in autoimmune disease
10. Certain diseases, birth defects may be linked to failure of protein recycling system
11. Researchers discover protein that controls bone growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: